Loading...
Zura Bio Limited
94E.F•XETRA
Healthcare
Biotechnology
€1.20
€-0.09(-6.98%)
Zura Bio Limited (94E.F) Company Profile & Overview
Explore Zura Bio Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Zura Bio Limited (94E.F) Company Profile & Overview
Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in San Diego, California.
SectorHealthcare
IndustryBiotechnology
CEORobert Lisicki
Contact Information
Company Facts
30 Employees
IPO DateMar 21, 2023
CountryUS
Actively Trading